Life Sciences

  • Microbiome / Nutrition / Foodtech / Lifestyle
  • Connected Health & Food / Wellness
  • Biotech & Pharmaceuticals
  • Medtech & Diagnosis
  • Industrial Biotech

Read more

Digital Technologies

  • Fintech
  • Saas Software Editor
  • Innovative Services
  • Infrastructure Technologies

Read more

News

  • Expensya
    13 December 2018

    Expensya

    Expensya reinvents expense reporting thanks to...

  • Israeli microbiome co BiomX teams with Johnson & Johnson
    13 December 2018

    Israeli microbiome co BiomX teams with Johnson & Johnson

    Israeli microbiome company BiomX, which is developing...

  • Expensya raises 4M€ in Series A Financing co-lead by ISAI and Seventure Partners
    13 December 2018

    Expensya raises 4M€ in Series A Financing co-lead by ISAI and Seventure Partners

    The company, that develops and sells an innovative...

    Read more...
  • Next decade set to herald industry confidence in microbiome-based therapies, says new report
    5 November 2018

    Next decade set to herald industry confidence in microbiome-based therapies, says new report

    Taking on board learnings from challenges already faced...

    Read more...
  • Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development
    26 October 2018

    Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development

    Proceeds to fund Phase 2/3 trial of inhaled TD139 in...

    Read more...

Events

  • 25 September

    France Digitale Day, Paris

    Come & meet us !

  • 04 October

    Fintech Tour – 4 October 2018 – MARSEILLE

    Come & meet us ! http://bit.ly/2Ck2iBo

  • 29 January

    Microbiome Drug Development Summit – Paris, 29-31 January

    Come & meet us !

Twitter

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse